Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
about
A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicinesSalvianolic acid B inhibits hydrogen peroxide-induced endothelial cell apoptosis through regulating PI3K/Akt signalingTanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathwaySynergism of Chinese Herbal Medicine: Illustrated by Danshen CompoundTherapeutic Effects of Traditional Chinese Medicine on Spinal Cord Injury: A Promising Supplementary Treatment in FutureNew Potential Pharmacological Functions of Chinese Herbal Medicines via Regulation of AutophagyRecent advances in biosynthesis of bioactive compounds in traditional Chinese medicinal plantsChemical Analysis of the Herbal Medicine Salviae miltiorrhizae Radix et Rhizoma (Danshen)Recent insights into the biological activities and drug delivery systems of tanshinonesDirect stimulation of adult neural stem/progenitor cells in vitro and neurogenesis in vivo by salvianolic acid BSodium tanshinone IIA silate inhibits high glucose-induced vascular smooth muscle cell proliferation and migration through activation of AMP-activated protein kinaseSalvianolic acid B reverses the epithelial-to-mesenchymal transition of HK-2 cells that is induced by transforming growth factor-βSalvianolic Acid B (Sal B) Protects Retinal Pigment Epithelial Cells from Oxidative Stress-Induced Cell Death by Activating Glutaredoxin 1 (Grx1)Cardio-protection of salvianolic acid B through inhibition of apoptosis networkEfficient conversion of phenylpyruvic acid to phenyllactic acid by using whole cells of Bacillus coagulans SDM.Salvianolic acid B prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenesisA system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatmentTranscriptome analysis of medicinal plant Salvia miltiorrhiza and identification of genes related to tanshinone biosynthesisIn vivo angiogenesis screening and mechanism of action of novel tanshinone derivatives produced by one-pot combinatorial modification of natural tanshinone mixture from Salvia miltiorrhizaSalvianolic acid B attenuates toxin-induced neuronal damage via Nrf2-dependent glial cells-mediated protective activity in Parkinson's disease modelsThe vascular effects of sodium tanshinone IIA sulphonate in rodent and human pregnancyExtracts of Salvia miltiorrhiza Bunge on the cytokines of rat endometriosis modelsProtective effects of tanshinone ⅡA on endothelial progenitor cells injured by tumor necrosis factor-α.Past achievements, current status and future perspectives of studies on 3-hydroxy-3-methylglutaryl-CoA synthase (HMGS) in the mevalonate (MVA) pathway.An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-YinPreparation of przewalskinic acid A from salvianolic acid B using a crude enzyme from an Aspergillus oryzae strain.Transcriptional data mining of Salvia miltiorrhiza in response to methyl jasmonate to examine the mechanism of bioactive compound biosynthesis and regulation.Synthesis, characterization and anticancer activity of tanshinone I grafted low molecular chitosan.MS-1020 is a novel small molecule that selectively inhibits JAK3 activity.Identification of a Novel (-)-5-Epieremophilene Synthase from Salvia miltiorrhiza via Transcriptome MiningGeneration and analysis of expressed sequence tags from the medicinal plant Salvia miltiorrhiza.Protective efficacy of a single salvianolic acid A treatment on photothrombosis-induced sustained spatial memory impairmentsSalvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases.The endophytic fungi of Salvia miltiorrhiza Bge.f. alba are a potential source of natural antioxidants.Activation tagging in Salvia miltiorrhiza can cause increased leaf size and accumulation of tanshinone I and IIA in its rootsChromosome engineering of Escherichia coli for constitutive production of salvianic acid ACryptotanshinone reverses reproductive disturbances in rats with dehydroepiandrosterone-induced polycystic ovary syndrome.Tanshinone IIA attenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation.Attenuation of renal ischemic reperfusion injury by salvianolic acid B via suppressing oxidative stress and inflammation through PI3K/Akt signaling pathway.Differential proteomic analysis of platelets suggested possible signal cascades network in platelets treated with salvianolic acid B.
P2860
Q21090750-0C68AF51-CB29-44E9-B28F-A4AC66EB4875Q21144404-95F63F58-5404-4119-BC48-6F05C4CF154EQ24616719-D0810C9A-3B9A-41B0-BD55-D42DC74AF44BQ26748772-FF9872F3-6DDD-4F40-88FE-2FC08A983A4FQ26749447-75B3AB79-5BCD-43A8-B02B-110528067700Q26753053-FD350152-5BAE-4FE0-A75B-E85D859D0275Q26769057-D7952567-0531-4930-A114-5978992C031EQ26770304-C127C8A6-2F42-44BB-AE71-456352BEA18FQ26770498-756F2F47-4000-455D-8F72-B1B31F4F716BQ27304153-D108BE4D-88E9-43ED-830B-6432379FEF25Q27339789-E12261F5-623D-4183-ACB9-1F21DB971E67Q28236906-693D7F3E-389F-417E-99DE-BD45856CBCE7Q28395633-BA02D7DA-341B-4A99-8AA9-A27D017B4AF6Q28476812-FA7E41C0-B032-4A37-922B-84B061091632Q28477843-55B31654-487C-4A11-A600-1951519D33F3Q28482176-243EDDE9-40B6-45E0-8BC3-D0C223CCE3B6Q28483412-A1BD9048-A46E-4597-806A-7C1B0513DC7AQ28535270-F3D2DD7A-3FF2-4BCA-8150-EF2314D32729Q28540301-D31C823D-3915-42B9-A948-927443CB8F9BQ28540349-2F15306A-55E3-448B-8596-B09D5963D305Q28545010-E5EFD656-C133-406E-969D-4DBD756087A4Q28583414-4E5AE013-C3BF-4CB1-9E78-27B7C8DA2C22Q29347118-03212C73-7136-40E8-923A-AF23CCFD15D5Q30360799-6CFAC6DD-2E0E-4509-A638-AB7F4ED76B40Q30393827-1B9A945C-32C2-4A04-A656-544CD8DC39B4Q30774432-1638A4AA-CFB9-40C7-A68E-5B1AFDCEDEA8Q30784130-31A11871-FD7D-4044-A873-11DCF604004BQ31130744-44243E25-7CEC-48D7-BDF1-754D9AA2EE23Q33507716-210B85E9-56AD-43B8-9BBC-9DB251DE7C73Q33601330-45E11919-AE2B-415D-BE65-BDD0EB80C8A8Q33623858-FF112BBB-8CA8-44E3-B157-FD99A46F46ADQ33631320-2C90B4B0-9A26-482C-84F6-15DDC01B7792Q33646549-8352B67C-972A-43DA-AAC5-22A782A7F71DQ33680316-CDF5902A-B89C-46C8-B210-461CB57A3C1DQ33690566-3D69885D-B62C-4307-A0F4-647C3EC30A5AQ33696837-EBA7A3FF-011A-42BD-8953-CA8D2F7994FAQ33733239-4E66071F-FB20-432A-92FD-B996DAACD42FQ33761954-578D25D7-BDE1-4094-AFA2-BC9EA2904EF9Q33821366-0A8696C2-2723-412F-975D-33E2201C47C8Q33838313-F1DB025A-90B6-45E0-A68F-C1B84291EAD5
P2860
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
@ast
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
@en
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
@nl
type
label
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
@ast
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
@en
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
@nl
prefLabel
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
@ast
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
@en
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
@nl
P2093
P2860
P3181
P356
P1476
Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
@en
P2093
Limin Zhou
Moses Sing Sum Chow
P2860
P304
P3181
P356
10.1177/0091270005282630
P407
P577
2005-12-01T00:00:00Z